Chester County News and Community Website
YARDLEY, PA — Optinose (NASDAQ: OPTN) has announced its financial results for the year and quarter ending December 31, 2024, spotlighting strong growth in XHANCE prescriptions and revenue. The company also …
Optinose Reports 2024 Financial Results, Highlights Prescription Growth and First Operational Income Read More YARDLEY, PA — Optinose (NASDAQ: OPTN) has announced preliminary unaudited net product revenue of $22.4 million for the fourth quarter of 2024, driven by sustained growth in prescriptions for XHANCE® (fluticasone …
Optinose Reports $22.4 Million in Preliminary Q4 Revenue for XHANCE Read More YARDLEY, PA — Optinose, Inc. (NASDAQ: OPTN) has announced a 1-for-15 reverse stock split, set to take effect on December 30, 2024, at 5:00 p.m. Eastern Time. Starting December 31, …
Optinose Announces 1-for-15 Reverse Stock Split Read More YARDLEY, PA — Optinose (NASDAQ: OPTN) has released its financial results for the third quarter of 2024, revealing an increase in net revenue from its flagship product, XHANCE, and adjustments …
Optinose Reports Q3 2024 Financial Results, Highlights XHANCE Performance Read More